Cancer Genetics and Epigenetics 2024, Vol.12, No.3, 115-124 http://medscipublisher.com/index.php/cge 121 diverse environmental factors and the presence of different molecular subtypes within the same tumor, making it challenging to develop universal therapeutic strategies (Capparelli and Iannelli, 2022). The complexity of GC necessitates a comprehensive understanding of the molecular mechanisms underlying its pathogenesis to identify effective biomarkers and therapeutic targets (Yoda et al., 2015; Khorasani et al., 2021). 6.2 Technical limitations The study of genetic and epigenetic regulation in GC is hindered by several technical limitations. High-throughput sequencing technologies, while powerful, often generate vast amounts of data that require sophisticated bioinformatics tools for analysis and interpretation (Kang et al., 2017). Additionally, the detection of epigenetic modifications, such as DNA methylation and histone modifications, demands highly sensitive and specific assays, which can be technically challenging and costly (Ebrahimi et al., 2020). The variability in sample quality and the need for large, well-characterized cohorts further complicate the identification of consistent and clinically relevant biomarkers (Canale et al., 2020). Moreover, the integration of multi-omics data to provide a holistic view of the genetic and epigenetic landscape of GC remains a significant challenge (Zhou et al., 2018). 6.3 Biological variability Biological variability poses a significant challenge in the study of GC. The genetic and epigenetic landscape of GC can vary widely between patients, and even within different regions of the same tumor (Nemtsova et al., 2021; Capparelli and Iannelli, 2022). This intra-tumor heterogeneity can lead to differential responses to treatment and complicate the identification of universal biomarkers (Canale et al., 2020). Additionally, the dynamic nature of epigenetic modifications, which can be influenced by environmental factors and therapeutic interventions, adds another layer of complexity to the study of GC (Qu et al., 2013). Understanding the biological variability and its implications for disease progression and treatment response is crucial for the development of personalized therapeutic strategies. 7 Future Directions 7.1 Emerging technologies The landscape of gastric cancer research is rapidly evolving with the advent of new technologies that promise to enhance our understanding and treatment of this malignancy. High-throughput sequencing technologies, such as next-generation sequencing (NGS), have revolutionized the field by enabling comprehensive profiling of genetic and epigenetic alterations in gastric cancer (Yoda et al., 2015). These technologies facilitate the identification of novel biomarkers and therapeutic targets, which are crucial for early diagnosis and personalized treatment strategies. Additionally, the development of small molecule inhibitors targeting specific epigenetic regulators, such as BET inhibitors, has shown promising results in preclinical models of gastric cancer (Kang et al., 2017). These inhibitors work by preventing the binding of BET proteins to acetylated histones, thereby inhibiting the transcriptional activation of oncogenes like c-Myc, which are critical for cancer cell survival and proliferation. 7.2 Integrative and multi-omics approaches Integrative and multi-omics approaches are essential for a holistic understanding of gastric cancer. These approaches combine data from genomics, epigenomics, transcriptomics, proteomics, and metabolomics to provide a comprehensive view of the molecular alterations driving gastric cancer. For instance, the interplay between metabolic dysregulations and epigenetic modifications has been shown to contribute significantly to tumor progression (Crispo et al., 2019). By integrating multi-omics data, researchers can identify key regulatory networks and pathways that are disrupted in gastric cancer, leading to the discovery of novel therapeutic targets. Moreover, bioinformatics tools and algorithms are being developed to integrate and analyze these complex datasets, which will enhance our ability to infer the functional roles of specific genetic and epigenetic alterations in cancer (Kagohara et al., 2018). 7.3 Global and epidemiological studies Global and epidemiological studies are crucial for understanding the diverse etiological factors contributing to gastric cancer across different populations. These studies can provide insights into the genetic and epigenetic variations that influence cancer susceptibility and progression in various demographic groups. For example, the
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==